The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 21, 2017
Filed:
Aug. 20, 2014
Applicant:
Macrogenics, Inc., Rockville, MD (US);
Inventors:
Ezio Bonvini, Potomac, MD (US);
Leslie S. Johnson, Damestown, MD (US);
Ling Huang, Bethesda, MD (US);
Paul A. Moore, Bethesda, MD (US);
Gurunadh Reddy Chichili, Germantown, MD (US);
Ralph Froman Alderson, North Potomac, MD (US);
Assignee:
MacroGenics, Inc., Rockville, MD (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2896 (2013.01); C07K 16/2809 (2013.01); C07K 16/2866 (2013.01); A61K 2039/505 (2013.01); C07K 2317/31 (2013.01); C07K 2317/33 (2013.01); C07K 2317/56 (2013.01); C07K 2317/626 (2013.01); C07K 2317/73 (2013.01); C07K 2317/92 (2013.01); C07K 2319/30 (2013.01); C07K 2319/31 (2013.01);
Abstract
The present invention is directed to sequence-optimized CD 123×CD3 bi-specific monovalent diabodies that are capable of simultaneous binding to CD 123 and CD3, and to the uses of such diabodies in the treatment of hematologic malignancies.
Bonvini, Ezio. (2017). Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses thereof (U.S. Patent No. 9822181). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9822181
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile